Literature DB >> 21057838

Spinal mobility and its impact in Moroccan patients with ankylosing spondylitis.

Yousra Ibn Yacoub1, Bouchra Amine, Assia Laatiris, Redouane Abouqal, Najia Hajjaj-Hassouni.   

Abstract

The main objective of this cross-sectional study was to assess spinal mobility and its relationship with disease-related parameters of activity, severity, and quality of life in Moroccan patients with ankylosing spondylitis (AS). One hundred patients with AS according to New York Classification criteria were recruited. Chest expansion, Schober index, occiput-to-wall distance, and the combined index of Bath Ankylosing Spondylitis Metrology Index (BASMI) were used to assess spinal mobility. Assessment criteria included the evaluation of disease activity (Bath Ankylosing Spondylitis Disease Activity index), functional status (Bath Ankylosing Spondylitis Functional Index), and radiographic damage (Bath Ankylosing Spondylitis Radiologic Index).The short form-36 (SF-36) generic instrument was used to assess health-related quality of life. The mean age of patients was 38 ± 13 years. There were 67% of males in our data. Our patients had moderate disease activity, severe functional disability, and important radiological damage. The mean value of occiput-to-wall distance was 4 ± 6.2 cm, chest expansion was 3.4 ± 1.2 cm, Schober index was 2.7 ± 1.2 cm, and BASMI was 4 ± 3. Impaired spinal mobility, corresponding to higher scores of BASMI, had good statistically significant correlations with prolonged disease duration, severe functional disability (BASFI), important radiological damage (BASRI) and with the deterioration of most domains of SF-36 (p < 0.001). In our study, we state that functional status and radiographic damage are the main factors associated with limited spinal mobility. Also, altered spinal measurements had a negative impact on physical function domain of quality of life. Recognizing relationships between spinal mobility measures and clinical and radiological measures in AS can help us to develop early therapeutic strategies to reduce loss of spinal mobility in Moroccan patients.

Entities:  

Mesh:

Year:  2010        PMID: 21057838     DOI: 10.1007/s10067-010-1615-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?

Authors:  A Wanders; R Landewé; M Dougados; H Mielants; Sj van der Linden; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2005-07       Impact factor: 19.103

2.  Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis.

Authors:  Vladislava Vesović-Potić; Dusan Mustur; Dejana Stanisavljević; Tatjana Ille; Mihailo Ille
Journal:  Rheumatol Int       Date:  2009-01-27       Impact factor: 2.631

3.  Functional disability and quality of life in patients with ankylosing spondylitis.

Authors:  Elif E Bostan; Pinar Borman; Hatice Bodur; Nurdan Barça
Journal:  Rheumatol Int       Date:  2002-10-30       Impact factor: 2.631

4.  Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance.

Authors:  Liesbeth Heuft-Dorenbosch; Debby Vosse; Robert Landewé; Anneke Spoorenberg; Maxime Dougados; Herman Mielants; Hille van der Tempel; Sjef van der Linden; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2004-09       Impact factor: 4.666

5.  Relationship between spinal mobility and disease activity, function, quality of life and radiology. A cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER).

Authors:  R Almodóvar; P Zarco; E Collantes; C González; J Mulero; J L Fernández-Sueiro; J Gratacós; J C Torres-Alonso; X Juanola; E Batlle; R Ariza; E Muñoz
Journal:  Clin Exp Rheumatol       Date:  2009 May-Jun       Impact factor: 4.473

6.  Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome.

Authors:  Annelies Boonen; Bert vander Cruyssen; Kurt de Vlam; Serge Steinfeld; Clio Ribbens; Jan Lenaerts; Filip Van den Bosch; Herman Mielants; Lode Dewulf; Nathan Vastesaeger
Journal:  J Rheumatol       Date:  2009-05-15       Impact factor: 4.666

7.  Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis.

Authors:  Rafael Ariza-Ariza; Blanca Hernández-Cruz; Federico Navarro-Sarabia
Journal:  Arthritis Rheum       Date:  2003-08-15

8.  Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness.

Authors:  K L Haywood; A M Garratt; K Jordan; K Dziedzic; P T Dawes
Journal:  Rheumatology (Oxford)       Date:  2004-04-07       Impact factor: 7.580

9.  Health status of patients with ankylosing spondylitis: a comparison with the general population.

Authors:  H Dagfinrud; A M Mengshoel; K B Hagen; J H Loge; T K Kvien
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

10.  Quality of life in patients with ankylosing spondylitis: a pilot study.

Authors:  Yasemin Turan; Mehmet Tuncay Duruöz; Lale Cerrahoglu
Journal:  Rheumatol Int       Date:  2007-01-25       Impact factor: 3.580

View more
  3 in total

Review 1.  Spondyloarthritis in North Africa: an update.

Authors:  Samy Slimani; Wafa Hamdi; Kawtar Nassar; Asgar Ali Kalla
Journal:  Clin Rheumatol       Date:  2021-02-09       Impact factor: 2.980

2.  Relationship of the sexual functions with the clinical parameters, radiological scores and the quality of life in male patients with ankylosing spondylitis.

Authors:  Mustafa Akif Sariyildiz; Ibrahim Batmaz; Banu Dilek; Ahmet Inanir; Yasin Bez; Mehmet Tahtasiz; Serda Em; Remzi Cevik
Journal:  Rheumatol Int       Date:  2012-04-07       Impact factor: 2.631

Review 3.  Construct validity of clinical spinal mobility tests in ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Marcelo P Castro; Simon M Stebbings; Stephan Milosavljevic; Melanie D Bussey
Journal:  Clin Rheumatol       Date:  2015-09-04       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.